These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21110820)

  • 1. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
    Mathupala SP
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
    Shafaee A; Dastyar DZ; Islamian JP; Hatamian M
    Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugging cancer metabolism: Expectations vs. reality.
    Montrose DC; Galluzzi L
    Int Rev Cell Mol Biol; 2019; 347():1-26. PubMed ID: 31451211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
    Talekar M; Boreddy SR; Singh A; Amiji M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting metabolic remodeling in glioblastoma multiforme.
    Wolf A; Agnihotri S; Guha A
    Oncotarget; 2010 Nov; 1(7):552-62. PubMed ID: 21317451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis.
    Mathupala SP; Colen CB; Parajuli P; Sloan AE
    J Bioenerg Biomembr; 2007 Feb; 39(1):73-7. PubMed ID: 17354062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.
    Ononye SN; Shi W; Wali VB; Aktas B; Jiang T; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2014 Dec; 148(3):477-88. PubMed ID: 25395317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.
    Wang QQ; Li MX; Li C; Gu XX; Zheng MZ; Chen LX; Li H
    Curr Med Sci; 2020 Apr; 40(2):205-217. PubMed ID: 32337682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered metabolism in cancer: insights into energy pathways and therapeutic targets.
    Tufail M; Jiang CH; Li N
    Mol Cancer; 2024 Sep; 23(1):203. PubMed ID: 39294640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
    Sheng H; Tang W
    Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting metabolic dependencies in pediatric cancer.
    Issaq SH; Heske CM
    Curr Opin Pediatr; 2020 Feb; 32(1):26-34. PubMed ID: 31789976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle and energy metabolism in tumor cells: strategies for drug therapy.
    Amoedo ND; El-Bacha T; Rodrigues MF; Rumjanek FD
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):15-25. PubMed ID: 21110821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
    Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
    Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.